Lipoprotein (a) and its phenotype
Seishima, M.; Zhu, Y.; Abe, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 46-48
2004
ISSN/ISBN: 0047-1852 PMID: 15658259 Document Number: 582369
Document emailed within 1 workday
Related Documents
Berger, G.M.; Van der Westhuyzen, J.H.; Huskisson, J.; Bonnici, F.; Henderson, H.E. 1982: Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype South African Medical Journal 61(8): 266-272Idzior-Waluś, B. 1992: Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration Przeglad Lekarski 49(10): 327-333
Matsuda, Y. 1993: High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Kobe Journal of Medical Sciences 39(1): 1-14
Sánchez-Fayos, M.P.; Outeiriño, J.; Benítez, J.; Calabuig, T.; Prieto, E.; Sánchez-Guilarte, J.; Bosch, J.M.; Rodríguez, C.; Sánchez-Fayos, J. 1988: Hematologic phenotype versus cytogenic phenotype in 124 chronic myeloproliferative syndromes (1979-1987) Sangre 33(6): 491-496
Takada, H.; Hiromatsu, K.; Matsuzaki, G.; Muramori, K.; Nomoto, K. 1993: Peritoneal gamma delta T cells induced by Escherichia coli infection in mice. Correlation between Thy-1 phenotype and host minor lymphocyte-stimulating phenotype Journal of Immunology 151(4): 2062-2069
Klimov, A.N.; Serrano, D.S.; Kliueva, N.N.; Soliternova, I.B.; Nikul'cheva, N.G. 1985: Inhibition of lipoprotein lipolysis by polyarginine and evaluation of the mechanism of its interaction with lipoprotein lipase Biokhimiia 50(5): 804-813
Enzi, G.; Martini, S.; Baggio, G.; Baldo, G.; Digito, M.; Zanella, A. 1985: Lipoprotein metabolism in patients with elevated lipoprotein-lipase activity in adipose tissue International Journal of Obesity 9(Suppl 1): 173-176
Myers, D.E.; Huang, W.N.; Larkins, R.G. 1996: Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification American Journal of Physiology 271(5 Pt 1): C1504-C1511
Scanu, A.M. 1987: Lipoprotein(a): a genetically-determined lipoprotein variant in which a protein of the plasminogen family is linked to APO B100 Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 2(4): 259-265
Lasunción, M.A.; Alvarez, J.J.; Herrera, E. 1993: Lipoprotein(a): from hidden pre-beta lipoprotein to cardiovascular risk factor Medicina Clinica 101(11): 424-430
Oida, K.; Nakai, T.; Tamai, T.; Kutsumi, Y.; Kobayashi, T.; Hayashi, T.; Yamada, S.; Takeda, R. 1982: Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia Artery 10(4): 266-285
Monahan, L.K.; O'Kell, R.T.; Elliott, J.R. 1975: Low density lipoprotein cholesterol (CLDL) and lipoprotein phenotyping American Journal of Medical Technology 41(8): 307-309
Yoshino, G.; Hirano, T.; Kazumi, T. 1999: New clinical application of direct and chemical measurement of low density lipoprotein cholesterol-estimation of compositional changes in triglyceride-rich lipoprotein fraction Nihon Rinsho. Japanese Journal of Clinical Medicine 57(12): 2745-2753
Coquelet, M.L.; Jaeger, G.; de Traverse, P.M. 1970: Is the HbS greater than HbA phenotype or the HbC greater than HbA phenotype a peculiarity of the thalassemic trait in the African Negro? Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 997-1000
Tamachi, H.; Goto, Y. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 671-678
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260
Emancipator, K. 1992: Low bias in assayed values of lipoprotein antigens--lipoprotein(a) and apolipoproteins A-i and B--in midday postprandial blood specimens compared with morning fasting specimens Clinical Chemistry 38(3): 431-433
Saku, K.; Okamoto, T.; Takeda, Y.; Jimi, S.; Zhang, B.; Bai, H.; Liu, R.; Arakawa, K. 1996: Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats Artery 22(1): 36-48
Nimkuntod, P.; Tongdee, P. 2015: Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis Journal of the Medical Association of Thailand 98(Suppl 4): S58-S63